Kurt van Vloten

Person

Bellingham, MA, US

People

Patents Grantslast 30 patents

Information Patent Grant
NRF2 activator
- Patent number 10,968,181
- Issue date Apr 6, 2021
- Biogen MA Inc.
- Brian Stuart Lucas
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Heterocyclic compounds useful as PDK1 inhibitors
- Patent number 10,030,016
- Issue date Jul 24, 2018
- Sunesis Pharmaceuticals, Inc.
- Joseph Arndt
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Heterocyclic compounds useful as PDK1 inhibitors
- Patent number 9,546,165
- Issue date Jan 17, 2017
- Sunesis Pharmaceuticals, Inc.
- Joseph Arndt
- C07 - ORGANIC CHEMISTRY

Patents Applicationslast 30 patents

Information Patent Application
HETEROCYCLIC COMPOUNDS USEFUL AS PDK1 INHIBITORS
- Publication number 20240294524
- Publication date Sep 5, 2024
- Viracta Therapeutics, Inc.
- Joseph ARNDT
- C07 - ORGANIC CHEMISTRY
Information Patent Application
HETEROCYCLIC COMPOUNDS USEFUL AS PDK1 INHIBITORS
- Publication number 20230113598
- Publication date Apr 13, 2023
- Viracta Therapeutics, Inc.
- Joseph ARNDT
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
NRF2 ACTIVATOR
- Publication number 20210340107
- Publication date Nov 4, 2021
- Biogen MA Inc.
- Brian Stuart Lucas
- C07 - ORGANIC CHEMISTRY
Information Patent Application
HETEROCYCLIC COMPOUNDS USEFUL AS PDK1 INHIBITORS
- Publication number 20210070752
- Publication date Mar 11, 2021
- Sunesis Pharmaceuticals, Inc.
- Joseph ARNDT
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
NRF2 ACTIVATOR
- Publication number 20190345112
- Publication date Nov 14, 2019
- Biogen MA Inc.
- Brian Lucas
- C07 - ORGANIC CHEMISTRY
Information Patent Application
HETEROCYCLIC COMPOUNDS USEFUL AS PDK1 INHIBITORS
- Publication number 20190119268
- Publication date Apr 25, 2019
- Sunesis Pharmaceuticals, Inc.
- Joseph ARNDT
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
HETEROCYCLIC COMPOUNDS USEFUL AS PDK1 INHIBITORS
- Publication number 20160331756
- Publication date Nov 17, 2016
- Sunesis Pharmaceuticals, Inc.
- Joseph Arndt
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
HETEROCYCLIC COMPOUNDS USEFUL AS PDK1 INHIBITORS
- Publication number 20120208819
- Publication date Aug 16, 2012
- Joseph Arndt
- C07 - ORGANIC CHEMISTRY
Information Patent Application
HETEROARYL COMPOUNDS USEFUL AS RAF KINASE INHIBITORS
- Publication number 20120040951
- Publication date Feb 16, 2012
- Claudio Chuaqui
- C07 - ORGANIC CHEMISTRY

Kurt van Vloten

Person

Patents Grantslast 30 patents

NRF2 activator

Heterocyclic compounds useful as PDK1 inhibitors

Heterocyclic compounds useful as PDK1 inhibitors

Patents Applicationslast 30 patents

HETEROCYCLIC COMPOUNDS USEFUL AS PDK1 INHIBITORS

HETEROCYCLIC COMPOUNDS USEFUL AS PDK1 INHIBITORS

NRF2 ACTIVATOR

HETEROCYCLIC COMPOUNDS USEFUL AS PDK1 INHIBITORS

NRF2 ACTIVATOR

HETEROCYCLIC COMPOUNDS USEFUL AS PDK1 INHIBITORS

HETEROCYCLIC COMPOUNDS USEFUL AS PDK1 INHIBITORS

HETEROCYCLIC COMPOUNDS USEFUL AS PDK1 INHIBITORS

HETEROARYL COMPOUNDS USEFUL AS RAF KINASE INHIBITORS